European Society of Cardiology (ESC)

This page includes news from the European Society of Cardiology (ESC). The ESC represents more than 95,000 men and women in the field of cardiology from Europe, the Mediterranean basin. It is the European umbrella cardiology organization, which includes the European Association of Percutaneous Cardiovascular Interventions (EAPCI), which hosts the large EuroPCR meeting; the European Heart Rhythm Society (EHRA); European Association of Cardiovascular Imaging (EACVI); European Association of Preventive Cardiology (EAPC); and the Association for Acute Cardiovascular Care (ACVC).

Thumbnail

Echocardiography shows smoking is even more damaging to the heart than previously believed

Compared to the individuals without a history of smoking, both current and former smokers had thicker, weaker and heavier hearts.

Thumbnail

NSAID use may not be safe for older patients with type 2 diabetes

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022. 

Thumbnail

Medical marijuana linked to a higher risk of heart rhythm issues

The new analysis, presented at ESC Congress 2022, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. 

Transcatheter aortic valve replacement (TAVR) patients continue to benefit from an optimized pre- and post-procedural treatment strategy that utilizes the cusp overlap technique, according to new findings presented at EuroPCR 2022 in Paris.

Cusp overlap technique, optimized treatment strategy tied to significant improvements for TAVR patients

The research, presented at EuroPCR 2022 in Paris, represented an updated look at the Optimize PRO study, an ongoing analysis of patients treated with Medtronic’s self-expanding Evolut Pro and Pro+ TAVR systems.

Thumbnail

How the science behind COVID-19 vaccines could transform care for heart attack patients

A technique seen in the Pfizer-BioNTech and Moderna COVID-19 vaccines may be able to help heart cells repair themselves, according to new research out of the Netherlands. 

Thumbnail

European Society of Cardiology publishes new genetic testing guidelines for heart conditions

The new international consensus document gives detailed recommendations on when to offer genetic testing for patients and their family members. 

Women less likely to receive treatment, more likely to die after cardiogenic shock

Emerging data about differences in treatment for women and men may shed light on diverging outcomes.

There has been fear of a small number of patient who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination

COVID-19 vaccines safe for patients with a history of heart damage

“These results provide reassuring data that may encourage patients with a history of myocarditis to get vaccinated against SARS-CoV-2,” one specialist said.